SHANGHAI, March 18, 2011 /PRNewswire-Asia-FirstCall/ —
China-Biotics, Inc. (Nasdaq:
CHBT) (“China-Biotics” or “the Company”), the leading
developer, manufacturer and distributor of probiotics products in
China, today announced that the Company has entered into an
agreement with a US based nutritional product company.
This new contract marks the major milestone in the
China-Biotics’ corporate history as it is the first contract win
outside of China. The company’s R&D representatives recently
attended Natural Product Expo West in Anaheim, California, which
attracted approximately 3400 exhibitors and a wide array of health
food industry participants.
Mr. Jinan Song, CEO and Chairman of China-Biotics, commented,
“we are very excited about winning our first overseas customer, in
a market which not only carries the world’s leading standard in
food safety but also consumes large volume and varieties of health
food. This is a solid testimony that our product quality and
technology capability have been received by the international
market. With this new win, we are now officially a new contender
for the US market, which is historically dominated by European
probiotics producers. We are confident that this is just the start
of our future expansion in the international market.”
About China-Biotics
China-Biotics, Inc. (“China-Biotics” or “the Company”), a
leading manufacturer of biotechnology products and supplements,
engages in the research, development, marketing and distribution of
probiotics dietary supplements in China. Through its wholly owned
subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing
Bioengineering (Shanghai) Co. Ltd., the Company develops and
produces a proprietary product portfolio. Currently, its retail
products are sold over the counter, mainly through large
distributors, to pharmacies and supermarkets in Beijing,
Shanghai,
‘/>”/>
SOURCE